Category: Latest News
-

Twin Vee PowerCats shares climb after unveiling AI partnership with Fetch.AI
Shares of Twin Vee PowerCats Co. (NASDAQ:VEEE) increased by 3% following the company’s announcement of a strategic alliance with Fetch.AI to bring autonomous AI agents to its national marine marketplace. This collaboration will implement AI-driven “Basic Agents” across all active boat listings on BoatsForSale.com. These agents will provide instant, context-aware, conversational responses to buyers’ questions…
-

Microsoft partners with Idaho National Lab to speed up nuclear plant permits using AI
Microsoft (NASDAQ:MSFT) and the Idaho National Laboratory (INL) announced a collaboration on Wednesday aimed at speeding up the permitting process for new nuclear power plants by leveraging artificial intelligence technology. The partnership will deploy Microsoft’s AI tools to create detailed engineering and safety analysis reports required for construction permits and operating licenses at U.S. nuclear…
-

VCI Global shares soar after acquisition of fund management firm
VCI Global Limited (NASDAQ:VCIG) surged 40% following the announcement that it has signed a definitive agreement to acquire V Capital Fund Management Limited, a licensed fund management company regulated by the Labuan Financial Services Authority. The deal, completed at a nominal cost, will grant VCI Global immediate access to a regulated asset management framework based…
-

Apollo Global Management shares climb amid talks for Atletico Madrid stake
Apollo Global Management (NYSE:APO) shares increased 2.3% after reports emerged that the private equity giant is negotiating to acquire a substantial stake in the Spanish football club Atletico Madrid. According to sources cited by Expansion, Apollo is in discussions with Miguel Ángel Gil Marín regarding a multimillion-dollar investment in the club, which is currently valued…
-

Madrigal Pharmaceuticals shares surge after extended patent protection for MASH therapy
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) saw its stock climb 6.1% following the announcement that the U.S. Patent and Trademark Office has issued a Notice of Allowance for its MASH treatment, Rezdiffra. The patent safeguards the FDA-approved use of Rezdiffra (resmetirom), the first and only FDA-approved therapy for adults suffering from noncirrhotic MASH with moderate to advanced…
-

Progressive Corp shares rise following strong Q2 earnings beat
Progressive Corp. (NYSE:PGR) posted second-quarter results that exceeded analyst expectations by a wide margin, pushing its shares up 4.3% as investors welcomed the insurer’s solid profitability. For the quarter ending June 30, 2025, Progressive reported adjusted earnings per share of $5.40, outperforming the consensus estimate of $4.36 by $1.04. Revenue reached $20.08 billion, slightly under…
-

Qualigen Therapeutics shares surge after patent approvals in 25 countries
Qualigen Therapeutics (NASDAQ:QLGN) saw its stock jump 80% following news that it secured new patents spanning 25 countries for its cancer drug QN-302. The patents, titled “Substituted Naphthalene Diimides and Their Use,” cover both the product and the manufacturing processes for QN-302. This drug was developed by Professor Stephen Neidle and his team at University…
-

Unity Software shares jump after Jefferies boosts price target
Unity Software (NYSE:U) shares surged 8% in premarket trading on Wednesday following Jefferies analyst Brent Thill’s decision to raise his price target on the gaming software firm to a Street-high $35, up from $29. The upgrade comes amid growing optimism around Unity’s Vector product, with Thill highlighting that positive mentions rose from 7 in Q1…
-

Prologis falls short on Q2 profit but shares rise on positive outlook
Prologis Inc (NYSE:PLD) reported second-quarter earnings below Wall Street forecasts and lowered its full-year profit guidance. However, the revised outlook surpassed consensus expectations due to “strong” leasing demand. This upbeat forecast helped lift Prologis shares by 1.55% to $110 during premarket trading on light volume. The logistics-focused real estate investment trust posted Q2 earnings per…
-

Tempus AI shares climb after FDA approval of heart monitoring software
Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-Low EF software. This AI-driven tool is designed to detect patients who might have a low left ventricular ejection fraction (LVEF)—a key measure of how…